Evidence map›Paper›PMID 41019410›Full record

ArticleNanotechnology, science and applications2025

Harnessing Cationic Bilosomes to Create a Green Light-Triggered Nanoplatform for Skin Melanoma Treatment.

Ewelina Waglewska, Julita Kulbacka, Urszula Bazylińska

Abstract read
In one paragraph

Article in Nanotechnology, science and applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ewelina WaglewskaDepartment of Physical and Quantum Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland.ORCID 0000-0002-0180-3185
Julita KulbackaDepartment of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wroclaw, Poland.ORCID 0000-0001-8272-5440
Urszula BazylińskaDepartment of Physical and Quantum Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland.ORCID 0000-0002-7309-3696

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Vesicular drug delivery systems, including bilosome-based nanoparticles containing bile salts, have revolutionized the field of colloid chemistry, nanomedicine, and nanobiotechnology. Due to their versatility and adaptability to various applications, they have gained considerable attention among researchers, thus offering a promising pathway to achieve effective and targeted delivery of miscellaneous drugs. Purpose: This study presents a novel class of positively charged bilosomes with surface-associated poly(ethylene glycol) (PEG)-lipid, co-entrapped the anionic xanthene dye (Rose Bengal), and natural carotenoid pigment derived from the mold Methods: Bilosomal nanosystems were prepared using thin film hydration combined with sonication. The physicochemical properties of the vesicles were characterized, including particle size, zeta potential, entrapment efficiency, and morphology. Cellular uptake, cyto- and phototoxicity experiments were investigated in vitro against human melanoma cancer cells. Results: The multidrug bilosome formulation exhibited a particle size of less than 100 nm and a zeta potential of more than +40 mV, indicating beneficial properties for potential transdermal administration. In vitro biological experiments have shown remarkable antitumor efficacy against human skin epithelial (A375) and malignant (Me45) melanoma cell lines. After irradiating the samples with green light at a wavelength of 520-560 nm (10 J/cm Conclusion: Our encouraging results provide new potential candidates for preclinical development in innovative photodynamic therapy targeting melanoma and also pave the way for future therapeutic strategies with broad applications in many biological fields.

Indexed as

antitumor activityastaxanthinbile saltslipid-based nanovesicular systemsphyto-photodynamic therapyRose Bengal

Identifiers

PMID41019410
PMCPMC12474708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.